Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Evaluation for non-accidental trauma (NAT) and bleeding disorders in infants referred to pediatric hematology

Abbey Elsbernd, Shannon Carpenter, Lyndsey Hultman, James Anderst

Blood (2025) 146 (Supplement 1): 2677.

https://doi.org/10.1182/blood-2025-2677

Published: 2025

Journal Articles

Exploratory analysis from HAVEN 1–4 to further contextualize injection-site reactions among people with hemophilia A receiving emicizumab

Maya Bloomberg, Katherine Eakle, Markus Niggli, Christophe Dhalluin, Lucy Lee, Elise Lim, Shannon Carpenter

Blood (2025) 146 (Supplement 1): 4839.

https://doi.org/10.1182/blood-2025-4839

Published: 2025

Journal Articles

Relationship of sociodemographic factors to presentation and natural history of provoked venous thromboembolism in u.s. children: A secondary analysis of the multinational kids-DOTT trial

Hope Wilson, Maua Alleyne, Sanjay Ahuja, Ernest Amankwah, Aisha Bruce, Shannon Carpenter, Fernando Corrales-Medina, Craig Mullen, Arun Panigrahi, Lakshmi Srivaths, Courtney Thornburg, Anupam Verma, Gary Woods, Neil Goldenberg, Madhvi Rajpurkar

Blood (2025) 146 (Supplement 1): 2680.

https://doi.org/10.1182/blood-2025-2680

Published: 2025

Journal Articles

Current practices of anticoagulant utilization in pediatric patients with acute myeloid leukemia (AML)

Abbey Elsbernd, Natalie Grills, James Antoon, Kathryn Kyler, Lucas Orth, Timothy Savage, Matt Hall, Jennifer Goldman, Shannon Carpenter

Blood (2025) 146 (Supplement 1): 1342.

https://doi.org/10.1182/blood-2025-1342

Published: 2025

Journal Articles

Real-world use of prophylaxis in people with non-severe hemophilia in the United States: Insights from the athn transcends Study - hemophilia natural history arm

Fernando Corrales-Medina, Nana Afari-Dwamena, Amanda Blair, Shannon Carpenter, Clay Cohen, Maissaa Janbain, Janice Staber, Jonathan Schwartz, Michael Recht, Tammuella Chrisentery-Singleton

Blood (2025) 146 (Supplement 1): 4472.

https://doi.org/10.1182/blood-2025-4472

Published: 2025

Journal Articles

Natural History Of Inhibitor Recurrence Following Successful Immune Tolerance Induction

Ana G. Antun, MD, Paul Monahan, MD, Marilyn J. Manco-Johnson, MD, Michael Callaghan, MD, Guy Young, MD, Christine Knoll, MD, Shannon Carpenter, MD, MS, Joanna A. Davis, MD, Michael F. Guerrera, MD, Rebecca Kruse-Jarres, MD, MPH, Margaret V. Ragni, MD, MPH, Char Witmer, MD, MSCE, Courtney E. McCracken, PhD, Maralee Kanin, Christine L. Kempton, MD, MSc

Blood (2013) 122 (21): 1106.

https://doi.org/10.1182/blood.V122.21.1106.1106

Published: 2013

Journal Articles

Retrospective Review of Hematologic Evaluation in Children with Suspected Non-Accidental Injury, A First Step towards Evidence Based Guidelines.

Allison Paroskie, MD, Shannon Carpenter, MD, MS, Deborah Lowen, MD, James Anderst, MD, MSC, Michael R. DeBaun, MD, MPH, Robert F Sidonio, Jr., MD, MSc

Blood (2012) 120 (21): 2231.

https://doi.org/10.1182/blood.V120.21.2231.2231

Published: 2012

Journal Articles

Prophylactic Dosing of Anti-Inhibitor Coagulant Complex (FEIBA) Reduces Bleeding Frequency In Hemophilia A Patients with Inhibitors: Results of the Pro-FEIBA Study

Cindy A. Leissinger, MD, Eric Berntorp, MD, Chiara Biasioli, MD, Shannon Carpenter, MD, MS, Hyejin Jo, MS, Kaan Kavakli, MD, Claude Negrier, MD, Angiola Rocino, MD, Jerzy Windyga, MD, Bulent Zulfikar, MD, Alessandro Gringeri, MD

Blood (2010) 116 (21): 720.

https://doi.org/10.1182/blood.V116.21.720.720

Published: 2010

Journal Articles

Increased Prevalence of Inhibitors in Mexican-Hispanic Patients with Severe Hemophilia A Enrolled in the Universal Data Collection Project.

Shannon Carpenter, MD, MS, J. Michael Soucie, Ph.D., Sophia Sterner, MD, Rodney J Presley, PhD

Blood (2009) 114 (22): 3488.

https://doi.org/10.1182/blood.V114.22.3488.3488

Published: 2009

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Evaluation for non-accidental trauma (NAT) and bleeding disorders in infants referred to pediatric hematology

Exploratory analysis from HAVEN 1–4 to further contextualize injection-site reactions among people with hemophilia A receiving emicizumab

Relationship of sociodemographic factors to presentation and natural history of provoked venous thromboembolism in u.s. children: A secondary analysis of the multinational kids-DOTT trial

Current practices of anticoagulant utilization in pediatric patients with acute myeloid leukemia (AML)

Real-world use of prophylaxis in people with non-severe hemophilia in the United States: Insights from the athn transcends Study - hemophilia natural history arm

Natural History Of Inhibitor Recurrence Following Successful Immune Tolerance Induction

Retrospective Review of Hematologic Evaluation in Children with Suspected Non-Accidental Injury, A First Step towards Evidence Based Guidelines.

Prophylactic Dosing of Anti-Inhibitor Coagulant Complex (FEIBA) Reduces Bleeding Frequency In Hemophilia A Patients with Inhibitors: Results of the Pro-FEIBA Study

Increased Prevalence of Inhibitors in Mexican-Hispanic Patients with Severe Hemophilia A Enrolled in the Universal Data Collection Project.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only